John,

The cost of life-saving prescription medicine in America is out of control. According to a poll by Kaiser Family Health, eight in ten adults say that the cost of prescription drugs is unreasonable. And almost 30 percent aren’t taking their medication as prescribed due to cost.

Thanks to the Inflation Reduction Act that Congress passed in 2022, vital medication is becoming more affordable. For the first time, Medicare has the power to negotiate prescription drug prices. Insulin costs have been capped at $35 per month for Medicare patients as a result.

Now, Eli Lilly has announced they’ll be capping out-of-pocket costs for insulin at $35 a month for everyone.

Make no mistake, Eli Lilly would not have taken these steps without pressure from the public and the federal government to make insulin more affordable. This is a huge step towards lowering the cost of a prescription drug that millions rely on to survive. But other pharmaceutical companies continue to inflate prices for profit.

Sign the petition: Tell pharmaceutical companies to follow Eli Lilly’s lead and cap the cost of insulin at $35 a month.

Onward,

Ro

Do not worry if you cannot afford to make a contribution — we understand that this is a difficult time. If you’re struggling, you can find a food bank here. We appreciate everything you do to keep our movement strong. Please stay informed and follow the most up-to-date recommendations from the Centers for Disease Control and your state public health department.